v3.22.1
Additional paid-in capital (Tables)
3 Months Ended
Mar. 31, 2022
Additional Paid-in Capital  
Schedule of share-based compensation, stock options, activity
           
 

Three Months Ended

March 31, 2022

Year Ended

December 31, 2021

  Number of Options Weighted Average Exercise Price Number of Options Weighted Average Exercise Price
Outstanding, beginning of period 5,497,001,500 $ 0.006 5,362,701,500 $ 0.004
Granted - $ - 165,000,000 $ 0.050
Exercised - $ - (800,000) $ (0.015)
Cancelled (60,000,000) $ (0.036) (29,900,000) $ (0.034)
Outstanding, end of period 5,437,001,500 $ 0.005 5,497,001,500 $ 0.006
             
Exercisable, end of period 5,223,701,500 $ 0.004 5,221,701,500 $ 0.004
Schedule of Options Outstanding
 Schedule of Options Outstanding                    
  March 31, 2022 December 31, 2021
Expiry Date Options Exercise Price Intrinsic Value Options Exercise Price Intrinsic Value
                     
November 27, 2022 5,600,000 $ 0.015 $ 0.044 5,600,000 $ 0.015 $ 0.045
January 31, 2023 20,500,000 $ 0.015 $ 0.044 40,500,000 $ 0.015 $ 0.045
June 13, 2023 5,000,000 $ 0.015 $ 0.044 5,000,000 $ 0.015 $ 0.045
March 14, 2024 6,650,000 $ 0.035 $ 0.024 6,650,000 $ 0.035 $ 0.025
April 12, 2024 4,925,001,500 $ 0.002 $ 0.057 4,925,001,500 $ 0.002 $ 0.058
April 12, 2024 3,350,000 $ 0.015 $ 0.044 3,350,000 $ 0.015 $ 0.045
April 12, 2024 200,000 $ 0.030 $ 0.029 200,000 $ 0.030 $ 0.030
May 6, 2024 13,000,000 $ 0.035 $ 0.024 13,000,000 $ 0.035 $ 0.025
May 17, 2024 57,000,000 $ 0.050 $ 0.009 77,000,000 $ 0.050 $ 0.010
May 17, 2024 19,400,000 $ 0.035 $ 0.024 19,400,000 $ 0.035 $ 0.025
June 17, 2024 - $ - $ - 5,000,000 $ 0.050 $ 0.010
August 16, 2024 - $ - $ - 2,500,000 $ 0.050 $ 0.010
September 6, 2024 - $ - $ - 1,000,000 $ 0.050 $ 0.010
October 3, 2024 3,500,000 $ 0.035 $ 0.024 3,500,000 $ 0.035 $ 0.025
October 24, 2024 2,000,000 $ 0.035 $ 0.024 2,000,000 $ 0.035 $ 0.025
December 11, 2024 120,000,000 $ 0.015 $ 0.044 120,000,000 $ 0.015 $ 0.045
April 1, 2025 10,000,000 $ 0.035 $ 0.024 10,000,000 $ 0.035 $ 0.025
May 31, 2025 10,000,000 $ 0.035 $ 0.024 20,000,000 $ 0.035 $ 0.025
May 31, 2025 87,300,000 $ 0.050 $ 0.009 87,300,000 $ 0.050 $ 0.010
December 31, 2025 56,500,000 $ 0.050 $ 0.009 56,500,000 $ 0.050 $ 0.010
June 30, 2026 26,000,000 $ 0.050 $ 0.009 26,000,000 $ 0.050 $ 0.010
September 30, 2026 16,000,000 $ 0.050 $ 0.009 17,500,000 $ 0.050 $ 0.010
December 31, 2026 50,000,000 $ 0.050 $ 0.009 50,000,000 $ 0.050 $ 0.010
Total 5,437,001,500 $ 0.005 $ 0.053 5,497,001,500 $ 0.006 $ 0.054
                     
Weighted Average Remaining Contractual Life     2.13         2.37    

 

Schedule of Fair Value of Stock Options Granted-Allocation
Schedule of Fair Value of Stock Options Granted-Allocation          
  

Three Months Ended

March 31, 2022

 

Three Months Ended

March 31, 2021

Product development expense  $62,168   $36,145 
Professional expense   8,959    15,225 
Selling, general and administrative expenses   248,662       
Fair value of the stock options granted  $319,789   $51,370 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
          
  

March 31,

2022

 

December 31,

2021

Risk-free interest rate   N/A    0.87%
Expected life   N/A    4.8 years 
Expected dividends   N/A    0%
Expected volatility   N/A    278%
Forfeiture rate   N/A    0%